hotspot -WSS

hotspot

author：knowledge 2025-09-27 10:03:27 - browse：51436

Person wearing a blue glove holding money against a blue backdrop. — Adobe

Covid vaccines saved nearly 20 million lives worldwide, by one estimate, and generated billions of dollars for several drugmakers. But investment in experimental vaccines for dozens of other diseases remains modest and should be much higher, according to a new biotechnology industry report.

Even with the historic effort to develop coronavirus vaccines, including shots created by Cambridge, Mass.-based Moderna, drugmakers developing new vaccines for infectious diseases received 3.4% of all venture capital raised for biopharma companies in the past 10 years, for a total of $6.5 billion, the report said.

In comparison, firms with potential cancer drugs received 38% of venture capital, or $72.6 billion — 12 times as much — during the same period, according to the report by the Biotechnology Innovation Organization, or BIO, the world’s largest biotech trade group.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Fatty liver disease was alleviated by Lilly’s ‘triple

entertainment

WSS

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Readout LOUD podcast: mifepristone case, GLP

Prescription digital therapeutics are key to pharma’s future

Study says nonprofit hospitals fall short in charity care spending

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Washington mulls new rules to avert another Change Healthcare

Wikipedia

hotspot

focus

Psychedelics group wrestles with new pharma identity

Primary care physicians play key roles in Alzheimer's management

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: Merck, Vertex, and Viking updates

ChatGPT in medicine: STAT answers readers' burning questions

Lupron, used to halt puberty in children, may cause lasting health problems

DIEP, the 'gold standard' of breast reconstruction, is under threat

Abortion pill case raises question: who can sue the FDA?

After affirmative action ruling, medical educators look to 'holistic review'

Food as medicine: Medically tailored meals may get standardized

knowledge

What affirmative action's end means to a medical student

Prescription digital therapeutics are key to pharma’s future

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Fatty liver disease was alleviated by Lilly’s ‘triple

FDA's naming rule on biosimilars has undermined competition

leisure time

focus

entertainment

leisure time